Skip to main content
SpringerLink
Log in

Efficacy and safety of low-dose clopidogrel in Japanese patients after drug-eluting stent implantation: a randomized pilot trial

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

In Japan, a lower maintenance dose of ticlopidine is used than in the United States and Europe. Therefore a lower maintenance dose of clopidogrel may also be considered appropriate in Japanese patients. The present randomized pilot study evaluated the efficacy and safety of 50 mg clopidogrel in Japanese patients who underwent drug-eluting stent (DES) implantation. A total of 200 patients with 277 lesions who underwent intravascular ultrasound-guided DES implantation were enrolled. The subjects were allocated to the 50- or 75-mg clopidogrel group. All patients received 100 mg aspirin daily before the procedure, and this continued indefinitely. The duration of clinical follow-up was 21.8 ± 5.7 months in the 75-mg group and 21.9 ± 6.1 months in the 50-mg group (P = 0.96). During follow-up, no cardiac death, myocardial infarction, or stent thrombosis was observed in either group. Side effects of clopidogrel were observed in 4 patients (4.0 %) in the 75-mg group and in 4 patients (4.0 %) in the 50-mg group. Following this randomized pilot study, it may be justified to perform a large-scale randomized study comparing 50- and 75-mg dosing of clopidogrel in Japanese patients undergoing coronary stent implantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fukushima K, Kobayashi Y, Okuno T, Nakamura Y, Sakakibara M, Nakayama T, Kuroda N, Miyazaki A, Shimizu Y, Komuro I (2007) Incidence of side-effects of ticlopidine after sirolimus-eluting stent implantation. Circ J 71:617–619

    Article  CAS  PubMed  Google Scholar 

  2. Kitahara J, Kobayashi Y, Fujimoto Y, Nakamura Y, Nakayama T, Kuroda N, Himi T, Miyazaki A, Komuro I (2007) Late stent thrombosis in patients receiving ticlopidine and aspirin after sirolimus-eluting stent implantation. Circ J 72:168–169

    Article  Google Scholar 

  3. Nakayama A, Morita H, Ando J, Fujita H, Ohtsu H, Nagai R (2012) Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention. Heart Vessels. doi:10.1007/s00380-012-0248-3

    Google Scholar 

  4. Miyai N, Kinoshita N, Oota K, Yamada T, Nakamura R, Irie H, Hashimoto T, Tamaki S, Matsubara H (2011) Long-term angiographic outcomes of post-sirolimus-eluting stent restenosis in Japanese patients. Heart Vessels 26:168–175

    Article  PubMed  Google Scholar 

  5. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JP Jr, Cauhan MS, Rodriguez O, Kuntz RE (2001) Stent thrombosis in the modern era. A pooled analysis of multicenter coronary stent clinical trials. Circulation 103:1967–1971

    Article  CAS  PubMed  Google Scholar 

  6. Moussa I, Oetgen M, Roubin G, Colombo A, Wang X, Iyer S, Maida R, Collins M, Kreps E, Moses JW (1999) Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 99:2364–2366

    Article  CAS  PubMed  Google Scholar 

  7. Fukushima K, Kobayashi Y, Kitahara H, Iwata Y, Kuroda N, Ooyama M, Kuwabara Y, Nomura F, Komuro I (2010) Antiplatelet effect of 50 mg maintenance dose of clopidogrel compared to 200 mg ticlopidine: a preliminary study. Heart Vessels 25:1–41

    Article  Google Scholar 

  8. Ohkubo K, Kobayashi Y (2011) Long-term safety and efficacy of low-dose clopidogrel in Japanese patients undergoing coronary stenting. Cardiovasc Interv Ther 26:104–108

    Article  CAS  PubMed  Google Scholar 

  9. Asano T, Kobayashi Y, Fukushima K, Iwata Y, Kitahara H, Ishio N, Kuroda N, Komuro I (2008) Safety and efficacy of low-dose clopidogrel in Japanese patients undergoing coronary stenting: preliminary 30-day clinical outcome. Circ J 72:1707–1708

    Article  CAS  PubMed  Google Scholar 

  10. Colombo A, Orlic D, Stankovic G, Corvaja M, Spanos V, Montorfano M, Liistro F, Carlino M, Airoldi F, Chieffo A, Di Mario C (2003) Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 107:2178–2180

    Article  PubMed  Google Scholar 

  11. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694

    Article  CAS  PubMed  Google Scholar 

  12. Mauri L, Hsieh WH, Massaro JM, Ho KK, D’Agostio R, Cutlip DE (2007) Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356:1020–1029

    Article  CAS  PubMed  Google Scholar 

  13. Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, Iwamoto K, Tajiri M, J-ROCKET AF Study Investigators (2012) Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation—the J-ROCKET AF study. Circ J 76:2104–2111

    Article  CAS  PubMed  Google Scholar 

  14. Ohkubo K, Kobayashi Y, Nakamura Y, Miyazaki A (2011) Incidence of side effects of dual antiplatelet therapy with clopidogrel and aspirin after coronary stent implantation. Cardiovasc Interv Ther 26:33–37

    Article  CAS  PubMed  Google Scholar 

  15. Fujii K, Carlier SG, Mintz GS, Yand YM, Moussa I, Weisz G, Dangas G, Mahran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB (2005) Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45:995–998

    Article  CAS  PubMed  Google Scholar 

  16. Biondi-Zoccai GG, Agostoni P, Sangiorgi GM, Arioldi F, Cosgrave J, Chieffo A, Barbagallo R, Tamburino C, Vittori G, Falchetti E, Margheri M, Briguori C, Remigi E, Iakovou I, Colombo A, Real-world Eluting-stent Comparative Italian retrospective Evaluation Study Investigators (2006) Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation. Eur Heart J 27:540–546

    Article  PubMed  Google Scholar 

  17. Moreno R, Fernández C, Hernández R, Alfonso F, Angiolillo DJ, Sabaté M, Escaned J, Bañuelos C, Fernández-Ortiz A, Macaya C (2005) Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45:954–959

    Article  CAS  PubMed  Google Scholar 

  18. Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Weissman NJ, Lindsay J, Waksman R (2008) The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 29:1851–1857

    Article  CAS  PubMed  Google Scholar 

  19. Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP, COGENT Investigators (2010) Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 363:1909–1917

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-7-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan

    Kenji Ohkubo, Yoshihide Fujimoto, Yo Iwata, Hideki Kitahara, Tadayuki Kadohira, Kazumasa Sugimoto, Tomoki Morino & Yoshio Kobayashi

Authors
  1. Kenji Ohkubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihide Fujimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yo Iwata
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hideki Kitahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tadayuki Kadohira
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kazumasa Sugimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tomoki Morino
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshio Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenji Ohkubo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohkubo, K., Fujimoto, Y., Iwata, Y. et al. Efficacy and safety of low-dose clopidogrel in Japanese patients after drug-eluting stent implantation: a randomized pilot trial. Heart Vessels 29, 1–6 (2014). https://doi.org/10.1007/s00380-012-0318-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-012-0318-6

Keywords

Search

Navigation